Coloplast A/S (OTCMKTS:CLPBY) Stock Price Passes Above 50 Day Moving Average – Time to Sell?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $6.09 and traded as high as $6.70. Coloplast A/S shares last traded at $6.68, with a volume of 106,689 shares trading hands.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on CLPBY shares. The Goldman Sachs Group downgraded shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Coloplast A/S Stock Performance

The stock’s 50-day moving average price is $6.10 and its 200-day moving average price is $6.85. The company has a current ratio of 1.75, a quick ratio of 1.09 and a debt-to-equity ratio of 1.66. The company has a market capitalization of $15.10 billion, a P/E ratio of 47.86, a P/E/G ratio of 2.12 and a beta of 0.22.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.11 billion. As a group, equities analysts expect that Coloplast A/S Sponsored ADR will post 0.38 EPS for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.